Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
Cancer|April 29, 2025
Artificial intelligence-driven microsatellite instability profiling reveals distinctive genetic features in patients with lung cancerQuentin Dominique Thomas, Julie Adèle Vendrell, Lakhdar Khellaf, et al.Bulletin Du Cancer|January 14, 2022
[Combining surgery and medical treatments for ovarian cancer: Is there an optimal strategy?]Quentin Dominique Thomas, Stanislas Quesada, Véronique D'Hondt, et al.Cancers|March 13, 2024
Exploring the Efficacy of Pembrolizumab in Combination with Carboplatin and Weekly Paclitaxel for Frail Patients with Advanced Non-Small-Cell Lung Cancer: A Key Investigative StudyQuentin Dominique Thomas, Mohamed Chaabouni, Anas Al Herk, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 22, 2024
A comprehensive supportive care program for fine-tuning cancer immunotherapyAlexandre Tayart de Borms, Julien Colard-Thomas, Pierre-Ivan Laurent, et al.Cancers|November 9, 2024
Optimizing Treatment Strategies for <i>Egfr</i>-Mutated Non-Small-Cell Lung Cancer Treated with Osimertinib: Real-World Outcomes and InsightsQuentin Dominique Thomas, Nicolas Girard, Lise Bosquet, et al.Cancers|July 24, 2021
Generation and Characterization of a New Preclinical Mouse Model of EGFR-Driven Lung Cancer with MET-Induced Osimertinib ResistanceMaicol Mancini, Quentin-Dominique Thomas, Sylvia Bourdel, et al.Cancer Immunology, Immunotherapy : CII|February 12, 2026
Rituximab for severe immune checkpoint inhibitor-related adverse events: a multicenter case seriesStéphanie Hermabessiere, Benjamin Jauzelon, Steven Marmain, et al.British Journal of Cancer|November 17, 2023
Circulating tumour cells and PD-L1-positive small extracellular vesicles: the liquid biopsy combination for prognostic information in patients with metastatic non-small cell lung cancerZahra Eslami-S, Luis Enrique Cortés-Hernández, Léa Sinoquet, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 21, 2026
Advanced high-grade serous ovarian cancer treated with intensive cytoreductive surgery and chemotherapy: prognostic impact of lymph node involvement: analysis of the French national ESME-Unicancer databaseSophie Le Bars, Catherine Guerin-Charbonnel, Elodie Martin, et al.Gynecologic Oncology|August 15, 2022
Optimal timing of interval debulking surgery for advanced epithelial ovarian cancer: A retrospective study from the ESME national cohortQuentin Dominique Thomas, Amal Boussere, Jean-Marc Classe, et al.Pageof 3